ITMR News and Press, Itamar Medical Ltd. From 03/02/21

Itamar Medical Ltd. (ITMR) Q4 2020 Earnings Conference Call March 02, 2021 08:00 AM ET Company Participants Leigh Salvo - Investor Relations Gilad Glick - Chief Executive Officer Shy Basson - Chief Financial Officer Conference Call Participants Matthew O’Brien - Piper Sandler Josh Jenn...

Itamar Medical (ITMR): Q4 GAAP EPS of -$0.01 beats by $0.12.Revenue of $12.8M (+31.0% Y/Y) beats by $0.5M.FY2021 guidance: Revenue is expected to be in the range of $52M - 53M vs consensus of $40.28M, reflecting growth of 27% to 29% over FY 2020 of $41.0M.Press Release For further details s...

- Record Fourth Quarter 2020 Revenues Increase 31% to $ 12.8 Million - - U.S. WatchPAT™ Revenues Increase 39 % to $ 10.2 Million - - Full Year 2021 Revenue Guidance of $ ...

CAESAREA, Israel, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced today that it will report its financ...

ATLANTA, Feb. 16, 2021 (GLOBE NEWSWIRE) -- According to a survey commissioned by leading FDA cleared medical device and digital health company Itamar Medical Ltd. (NASDAQ and TASE: ITMR), 89% of respondents believe they know what sleep apnea is, yet deeper analysis of the data collected...

CAESAREA, Israel, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the company ...

CAESAREA, Israel, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (“Itamar Medical” or the “Company”) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the di...

Itamar Medical ([[ITMR]] +6.4%) priced its 3.05M ADS at $22.75/ADS; company is selling 1.97M ADSs and one of its shareholders, Viola Growth is selling 1.08M ADSs in the offering.Each ADS represents 30 ordinary shares of the company.Gross proceeds are expected to be ~$44.8M and gross...

CAESAREA, Israel, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (“Itamar Medical” or the “Company”) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the di...

CAESAREA, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Thursday, February 4th by Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), please note that the contact information was incorrect. The corrected release follows: Itamar Medical Ltd. ( ...